Demoxytocin: Difference between revisions
(Created page with "{{chembox | Verifiedfields = changed | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 2N9HM3X95F | verifiedrevid = 444602345 |ImageFile=Demoxytocin.svg |ImageSize= |IUPACName= 2-...") |
m (Protected "Demoxytocin": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(5 intermediate revisions by one other user not shown) | |||
Line 4: | Line 4: | ||
| UNII = 2N9HM3X95F | | UNII = 2N9HM3X95F | ||
| verifiedrevid = 444602345 | | verifiedrevid = 444602345 | ||
|ImageFile=Demoxytocin.svg | |ImageFile=Demoxytocin.svg.png | ||
|ImageSize= | |ImageSize= | ||
|IUPACName= 2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-''N''-(carbamoylmethyl)-4-methylpentanamide | |IUPACName= 2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-''N''-(carbamoylmethyl)-4-methylpentanamide | ||
Line 17: | Line 17: | ||
| KEGG = D07228 | | KEGG = D07228 | ||
| MeSHName=deaminooxytocin | | MeSHName=deaminooxytocin | ||
| ATCCode_prefix = H01 | | ATCCode_prefix = H01 | ||
| ATCCode_suffix = BB01 | | ATCCode_suffix = BB01 | ||
Line 36: | Line 35: | ||
}} | }} | ||
}} | }} | ||
__NOTOC__ | |||
'''Demoxytocin''' ([[International Nonproprietary Name|INN]], trade name '''Sandopart''') or '''deaminooxytocin''', is an [[obstetric]] [[pharmaceutical drug|drug]] often | {{SI}} | ||
{{CMG}} | |||
==Overview== | |||
'''Demoxytocin''' ([[International Nonproprietary Name|INN]], trade name '''Sandopart''') or '''deaminooxytocin''', is an [[obstetric]] [[pharmaceutical drug|drug]] often used in the prevention of [[puerperal]] [[mastitis]]. It is an [[analog (chemistry)|analogue]] of [[oxytocin]]. | |||
== References == | == References == | ||
Line 43: | Line 45: | ||
{{Pituitary and hypothalamic hormones and analogues}} | {{Pituitary and hypothalamic hormones and analogues}} | ||
[[Category:Neuropeptides]] | [[Category:Neuropeptides]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 19:41, 18 August 2015
{{chembox | Verifiedfields = changed | UNII_Ref = | UNII = 2N9HM3X95F | verifiedrevid = 444602345 |ImageFile=Demoxytocin.svg.png |ImageSize= |IUPACName= 2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-N-(carbamoylmethyl)-4-methylpentanamide |OtherNames= |Section1=! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers
|-
|
|
|-
| ChEMBL
|
|-
| ECHA InfoCard
| Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
|-
| KEGG
|
|- | MeSH | deaminooxytocin |-
|
|
|-
|Section2=! colspan=2 style="background: #f8eaba; text-align: center;" |Properties
|-
|
| C43H65N11O12S2
|- | Molar mass
| 992.1727
|- |Section3= }}
WikiDoc Resources for Demoxytocin |
Articles |
---|
Most recent articles on Demoxytocin Most cited articles on Demoxytocin |
Media |
Powerpoint slides on Demoxytocin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Demoxytocin at Clinical Trials.gov Clinical Trials on Demoxytocin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Demoxytocin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Demoxytocin Discussion groups on Demoxytocin Patient Handouts on Demoxytocin Directions to Hospitals Treating Demoxytocin Risk calculators and risk factors for Demoxytocin
|
Healthcare Provider Resources |
Causes & Risk Factors for Demoxytocin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demoxytocin (INN, trade name Sandopart) or deaminooxytocin, is an obstetric drug often used in the prevention of puerperal mastitis. It is an analogue of oxytocin.